Ownership Submission
|
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
OMB APPROVAL
|
|
OMB Number:3235-0104Expires:January 31, 2005Estimated average burden hours per response...0.5
|
|
|
1. Name and Address of Reporting Person *
|
|
Shutterly Andrew
|
|
2. Date of Event Requiring Statement (Month/Day/Year)
2024-06-26
|
3. Issuer Name and Ticker or Trading Symbol
Altimmune, Inc. [ALT]
|
|
(Last)
|
(First)
|
(Middle)
|
|
C/O ALTIMMUNE, INC. , 910 CLOPPER ROAD, SUITE 201S
|
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
_____ Director
|
_____ 10% Owner
|
|
_____ Officer (give title below)
|
_____ Other (specify below)
|
|
See Remarks /
|
|
5. If Amendment, Date Original Filed(Month/Day/Year)
|
(Street)
|
|
GAITHERSBURG
|
MD
|
20878
|
|
6. Individual or Join/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
|
|
Table I - Non-Derivative Securities Beneficially Owned
|
|
|
1.Title of Security
|
2. Amount of Securities Beneficially Owned
|
3. Ownership Form: Direct (D) or Indirect (I)
|
4. Nature of Indirect Beneficial Ownership
|
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
|
2. Date Exercisable and Expiration Date
|
3. Title and Amount of Securities Underlying Derivative Security
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
|
6. Nature of Indirect Beneficial Ownership
|
|
Date Exercisable
|
Expriation Date
|
Title
|
Amount or Number of Shares
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
|
Director
|
10% Owner
|
Officer
|
Other
|
Shutterly Andrew
C/O ALTIMMUNE, INC.
910 CLOPPER ROAD, SUITE 201S
GAITHERSBURG, MD20878
|
|
|
See Remarks
|
|
Signatures
|
/s/ Vipin K. Garg, as Attorney-in-Fact
|
2024-07-01
|
|
**Signature of Reporting Person
|
Date
|
Explanation of Responses:
|
(*)
|
If the form is filed by more than one reporting person, see Instruction 5(b)(v).
|
|
(**)
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
|
(1)
|
Twenty-five percent of the shares underlying the option became vested and exercisable on March 17, 2023 and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following March 17, 2023, subject to the reporting person's continued service through the applicable vesting date.
|
|
(2)
|
Twenty-five percent of the shares underlying the option became vested and exercisable on January 30, 2024 and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following January 30, 2024, subject to the reporting person's continued service through the applicable vesting date.
|
|
(3)
|
Twenty-five percent of the shares underlying the option became vested and exercisable on May 22, 2024 and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following May 22, 2024, subject to the reporting person's continued service through the applicable vesting date.
|
|
(4)
|
Twenty-five percent of the shares underlying the option become vested and exercisable on January 25, 2025 and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following January 25, 2025, subject to the reporting person's continued service through the applicable vesting date.
|
|
(5)
|
The RSUs will vest in equal annual installments of 3,750 shares on January 30, 2025, January 30, 2026 and January 30, 2027, subject to the reporting person's continued service through the applicable date, and have no expiration date.
|
|
(6)
|
The RSUs become vested and exercisable over four 4 years with 25% of the shares vesting on January 25, 2025, with the remainder vesting in equal annual installments for the following three years, subject to the reporting person's continued service through the applicable date, and have no expiration date.
|
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
See Instruction 6 for procedure.Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
